<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39194244</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-5514</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>17</Day></PubDate></JournalIssue><Title>Journal of virology</Title><ISOAbbreviation>J Virol</ISOAbbreviation></Journal><ArticleTitle>Coxsackievirus group B3 regulates ASS1-mediated metabolic reprogramming and promotes macrophage inflammatory polarization in viral myocarditis.</ArticleTitle><Pagination><StartPage>e0080524</StartPage><MedlinePgn>e0080524</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e00805-24</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/jvi.00805-24</ELocationID><Abstract><AbstractText Label="UNLABELLED">Coxsackievirus group B3 (CVB3) belongs to the genus <i>Enteroviruses</i> of the family <i>Picornaviridae</i> and is the main pathogen underlying viral myocarditis (VMC). No specific therapeutic is available for this condition. Argininosuccinate synthase 1 (ASS1) is a key enzyme in the urea cycle that converts citrulline and aspartic acid to argininosuccinate. Here, we found that CVB3 and its capsid protein VP2 inhibit the autophagic degradation of ASS1 and that CVB3 consumes citrulline to upregulate ASS1, triggers urea cycle metabolic reprogramming, and then activates macrophages to develop pro-inflammatory polarization, thereby promoting the occurrence and development of VMC. Conversely, citrulline supplementation to prevent depletion can downregulate ASS1, rescue macrophage polarization, and alleviate the pathogenicity of VMC. These findings provide a new perspective on the occurrence and development of VMC, revealing ASS1 as a potential new target for treating this disease.</AbstractText><AbstractText Label="IMPORTANCE" NlmCategory="OBJECTIVE">Viral myocarditis (VMC) is a common and potentially life-threatening myocardial inflammatory disease, most commonly caused by CVB3 infection. So far, the pathogenesis of VMC caused by CVB3 is mainly focused on two aspects: one is the direct myocardial injury caused by a large number of viral replication in the early stage of infection, and the other is the local immune cell infiltration and inflammatory damage of the myocardium in the adaptive immune response stage. There are few studies on the early innate immunity of CVB3 infection in myocardial tissue, but the appearance of macrophages in the early stage of CVB3 infection suggests that they can play a regulatory role as early innate immune response cells in myocardial tissue. Here, we discovered a possible new mechanism of VMC caused by CVB3, revealed new drug targets for anti-CVB3, and discovered the therapeutic potential of citrulline for VMC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Qiong</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-8950-6133</Identifier><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Shang</LastName><ForeName>Yinpan</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0009-0008-3071-3833</Identifier><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tao</LastName><ForeName>Ziwei</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hanchi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Second Clinical Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Zhili</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HuanKui Academy, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rao</LastName><ForeName>Zhirong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>HuanKui Academy, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Xiaomin</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-5824-0611</Identifier><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cao</LastName><ForeName>Yanli</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Lingbing</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University, School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xiaotian</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-1145-8386</Identifier><AffiliationInfo><Affiliation>The First Affiliated Hospital of Nanchang University and School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>82203032,32260193</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant><Grant><GrantID>32060040</GrantID><Agency>MOST | National Natural Science Foundation of China (NSFC)</Agency><Country /></Grant><Grant><GrantID>20212BCJ23036</GrantID><Agency>Training Plan for Academic and Technical Leaders of Major Disciplines in Jiangxi Province-Youth Talent Project</Agency><Country /></Grant><Grant><GrantID>jxsq2023301110, jxsq2023201019</GrantID><Agency>Project for high and talent of Science and Technology Innovation in Jiangxi Double-Thousand Program of Jiangxi Province</Agency><Country /></Grant><Grant><GrantID>202310403042, 202410403095, 202410403097</GrantID><Agency>National Innovation and Entrepreneurship Training Program for college students</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Virol</MedlineTA><NlmUniqueID>0113724</NlmUniqueID><ISSNLinking>0022-538X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 6.3.4.5</RegistryNumber><NameOfSubstance UI="D001124">Argininosuccinate Synthase</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D009205" MajorTopicYN="Y">Myocarditis</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="Y">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="Y">Macrophages</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003384" MajorTopicYN="Y">Coxsackievirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001124" MajorTopicYN="Y">Argininosuccinate Synthase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009206" MajorTopicYN="N">Myocardium</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000097784" MajorTopicYN="N">Metabolic Reprogramming</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">argininosuccinate synthase 1</Keyword><Keyword MajorTopicYN="N">coxsackievirus group B3</Keyword><Keyword MajorTopicYN="N">macrophages</Keyword><Keyword MajorTopicYN="N">viral myocarditis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>18</Day><Hour>5</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>28</Day><Hour>9</Hour><Minute>4</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39194244</ArticleId><ArticleId IdType="pmc">PMC11406948</ArticleId><ArticleId IdType="doi">10.1128/jvi.00805-24</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pollack A, Kontorovich AR, Fuster V, Dec GW. 2015. Viral myocarditis—diagnosis, treatment options, and current controversies. Nat Rev Cardiol 12:670–680. doi:10.1038/nrcardio.2015.108</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2015.108</ArticleId><ArticleId IdType="pubmed">26194549</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrouli MD, Spanakis N, Levidiotou S, Politi C, Alexiou S, Tseliou P, Hatzitaki M, Foundouli K, Tsakris A, Legakis NJ, Routsias JG. 2007. Serologic prevalence of coxsackievirus group B in Greece. Viral Immunol 20:11–18. doi:10.1089/vim.2006.0085</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vim.2006.0085</ArticleId><ArticleId IdType="pubmed">17425417</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairley CK, Ryan M, Wall PG, Weinberg J. 1996. The organisms reported to cause myocarditis and pericarditis in England and Wales. J Infect 32:223–225. doi:10.1016/S0163-4453(96)80023-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0163-4453(96)80023-5</ArticleId><ArticleId IdType="pubmed">8793712</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Zhang H, Wang X, Guo J, Wei L, Song Y, Luo Y, Zhao Y, Subramaniam M, Spelsberg TC, Wang L, Xu W, Li M. 2021. Kruppel-like factor 10 protects against acute viral myocarditis by negatively regulating cardiac MCP-1 expression. Cell Mol Immunol 18:2236–2248. doi:10.1038/s41423-020-00539-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00539-x</ArticleId><ArticleId IdType="pmc">PMC8429749</ArticleId><ArticleId IdType="pubmed">32895486</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairweather D, Frisancho-Kiss S, Gatewood S, Njoku D, Steele R, Barrett M, Rose NR. 2004. Mast cells and innate cytokines are associated with susceptibility to autoimmune heart disease following coxsackievirus B3 infection. Autoimmunity 37:131–145. doi:10.1080/0891693042000196200</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0891693042000196200</ArticleId><ArticleId IdType="pubmed">15293883</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasrado N, Reddy J. 2020. An overview of the immune mechanisms of viral myocarditis. Rev Med Virol 30:1–14. doi:10.1002/rmv.2131</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2131</ArticleId><ArticleId IdType="pubmed">32720461</ArticleId></ArticleIdList></Reference><Reference><Citation>Esfandiarei M, McManus BM. 2008. Molecular biology and pathogenesis of viral myocarditis. Annu Rev Pathol 3:127–155. doi:10.1146/annurev.pathmechdis.3.121806.151534</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pathmechdis.3.121806.151534</ArticleId><ArticleId IdType="pubmed">18039131</ArticleId></ArticleIdList></Reference><Reference><Citation>McNally EM. 2020. Cardiac macrophages - keeping the engine running clean. N Engl J Med 383:2474–2476. doi:10.1056/NEJMcibr2030271</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcibr2030271</ArticleId><ArticleId IdType="pubmed">33326720</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolás-Ávila JA, Lechuga-Vieco AV, Esteban-Martínez L, Sánchez-Díaz M, Díaz-García E, Santiago DJ, Rubio-Ponce A, Li JL, Balachander A, Quintana JA, et al. . 2020. A network of macrophages supports mitochondrial homeostasis in the heart. Cell 183:94–109. doi:10.1016/j.cell.2020.08.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.031</ArticleId><ArticleId IdType="pubmed">32937105</ArticleId></ArticleIdList></Reference><Reference><Citation>Cihakova D, Barin JG, Afanasyeva M, Kimura M, Fairweather D, Berg M, Talor MV, Baldeviano GC, Frisancho S, Gabrielson K, Bedja D, Rose NR. 2008. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am J Pathol 172:1195–1208. doi:10.2353/ajpath.2008.070207</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2008.070207</ArticleId><ArticleId IdType="pmc">PMC2329830</ArticleId><ArticleId IdType="pubmed">18403598</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi M, Usui F, Karasawa T, Kawashima A, Kimura H, Mizushina Y, Shirasuna K, Mizukami H, Kasahara T, Hasebe N, Takahashi M. 2016. NLRP3 deficiency reduces macrophage interleukin-10 production and enhances the susceptibility to doxorubicin-induced cardiotoxicity. Sci Rep 6:26489. doi:10.1038/srep26489</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep26489</ArticleId><ArticleId IdType="pmc">PMC4880937</ArticleId><ArticleId IdType="pubmed">27225830</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavine KJ, Pinto AR, Epelman S, Kopecky BJ, Clemente-Casares X, Godwin J, Rosenthal N, Kovacic JC. 2018. The macrophage in cardiac homeostasis and disease: JACC macrophage in CVD series (part 4). J Am Coll Cardiol 72:2213–2230. doi:10.1016/j.jacc.2018.08.2149</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.08.2149</ArticleId><ArticleId IdType="pmc">PMC6209119</ArticleId><ArticleId IdType="pubmed">30360829</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagar S, Liu PP, Cooper LT. 2012. Myocarditis. Lancet 379:738–747. doi:10.1016/S0140-6736(11)60648-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60648-X</ArticleId><ArticleId IdType="pmc">PMC5814111</ArticleId><ArticleId IdType="pubmed">22185868</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray PJ. 2017. Macrophage polarization. Annu Rev Physiol 79:541–566. doi:10.1146/annurev-physiol-022516-034339</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-022516-034339</ArticleId><ArticleId IdType="pubmed">27813830</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, Klingel K, Kandolf R, Sechtem U, Cooper LT, Böhm M. 2012. Update on myocarditis. J Am Coll Cardiol 59:779–792. doi:10.1016/j.jacc.2011.09.074</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2011.09.074</ArticleId><ArticleId IdType="pubmed">22361396</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K, Xu W, Guo Q, Jiang Z, Wang P, Yue Y, Xiong S. 2009. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis. Circ Res 105:353–364. doi:10.1161/CIRCRESAHA.109.195230</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.109.195230</ArticleId><ArticleId IdType="pubmed">19608981</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawrence T, Natoli G. 2011. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11:750–761. doi:10.1038/nri3088</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3088</ArticleId><ArticleId IdType="pubmed">22025054</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bossche J, O’Neill LA, Menon D. 2017. Macrophage immunometabolism: where are we (going)? Trends Immunol 38:395–406. doi:10.1016/j.it.2017.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2017.03.001</ArticleId><ArticleId IdType="pubmed">28396078</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Y, Shi D, Li G, Jiang P. 2022. Citrulline depletion by ASS1 is required for proinflammatory macrophage activation and immune responses. Mol Cell 82:527–541. doi:10.1016/j.molcel.2021.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.12.006</ArticleId><ArticleId IdType="pubmed">35016033</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P-S, Chen Y-T, Li X, Hsueh P-C, Tzeng S-F, Chen H, Shi P-Z, Xie X, Parik S, Planque M, Fendt S-M, Ho P-C. 2023. CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions. Nat Immunol 24:452–462. doi:10.1038/s41590-023-01430-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01430-3</ArticleId><ArticleId IdType="pmc">PMC9977680</ArticleId><ArticleId IdType="pubmed">36823405</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajaj E, Sciacovelli M, Frezza C, Erez A. 2021. The context-specific roles of urea cycle enzymes in tumorigenesis. Mol Cell 81:3749–3759. doi:10.1016/j.molcel.2021.08.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2021.08.005</ArticleId><ArticleId IdType="pubmed">34469752</ArticleId></ArticleIdList></Reference><Reference><Citation>Lercher A, Bhattacharya A, Popa AM, Caldera M, Schlapansky MF, Baazim H, Agerer B, Gürtl B, Kosack L, Májek P, et al. . 2019. Type I interferon signaling disrupts the hepatic urea cycle and alters systemic metabolism to suppress T cell function. Immunity 51:1074–1087. doi:10.1016/j.immuni.2019.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.10.014</ArticleId><ArticleId IdType="pmc">PMC6926485</ArticleId><ArticleId IdType="pubmed">31784108</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg AM, Stålhandske POK, Pettersson U. 1987. Genome of coxsackievirus B3. Virology (Auckl) 156:50–63. doi:10.1016/0042-6822(87)90435-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(87)90435-1</ArticleId><ArticleId IdType="pubmed">3027968</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson MF, Baltimore D. 1968. Polypeptide cleavages in the formation of poliovirus proteins. Proc Natl Acad Sci USA 61:77–84. doi:10.1073/pnas.61.1.77</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.61.1.77</ArticleId><ArticleId IdType="pmc">PMC285907</ArticleId><ArticleId IdType="pubmed">4301595</ArticleId></ArticleIdList></Reference><Reference><Citation>Henke A, Launhardt H, Klement K, Stelzner A, Zell R, Munder T. 2000. Apoptosis in coxsackievirus B3-caused diseases: interaction between the capsid protein VP2 and the proapoptotic protein siva. J Virol 74:4284–4290. doi:10.1128/jvi.74.9.4284-4290.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.74.9.4284-4290.2000</ArticleId><ArticleId IdType="pmc">PMC111945</ArticleId><ArticleId IdType="pubmed">10756043</ArticleId></ArticleIdList></Reference><Reference><Citation>De Giusti CJ, Ure AE, Rivadeneyra L, Schattner M, Gomez RM. 2015. Macrophages and galectin 3 play critical roles in CVB3-induced murine acute myocarditis and chronic fibrosis. J Mol Cell Cardiol 85:58–70. doi:10.1016/j.yjmcc.2015.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2015.05.010</ArticleId><ArticleId IdType="pubmed">26002282</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Dong C, Xiong S. 2017. IL-33 enhances macrophage M2 polarization and protects mice from CVB3-induced viral myocarditis. J Mol Cell Cardiol 103:22–30. doi:10.1016/j.yjmcc.2016.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2016.12.010</ArticleId><ArticleId IdType="pubmed">28041873</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Hui, Yue Y, Sun T, Wu X, Xiong S. 2017. Transmissible endoplasmic reticulum stress from myocardiocytes to macrophages is pivotal for the pathogenesis of CVB3-induced viral myocarditis. Sci Rep 7:42162. doi:10.1038/srep42162</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42162</ArticleId><ArticleId IdType="pmc">PMC5296968</ArticleId><ArticleId IdType="pubmed">28176833</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang YZ, Guo Q, Zhou TS, Zhang J, Li L, Jin PY, Wu WZ, Shen JY, Yang JH, Peng BZ. 1993. Electrophysiological and pathological observations on experimental coxsackie B-3 viral myocarditis in mice. Chin Med J (Engl) 106:100–104.</Citation><ArticleIdList><ArticleId IdType="pubmed">8389271</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Wang X, Qu M, Li Z, Yin X, Tang L, Liu X, Sun Y. 2023. Foot-and-mouth disease virus structural protein VP3 interacts with HDAC8 and promotes its autophagic degradation to facilitate viral replication. Autophagy 19:2869–2883. doi:10.1080/15548627.2023.2233847</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2023.2233847</ArticleId><ArticleId IdType="pmc">PMC10549200</ArticleId><ArticleId IdType="pubmed">37408174</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi J, Wong J, Piesik P, Fung G, Zhang J, Jagdeo J, Li X, Jan E, Luo H. 2013. Cleavage of sequestosome 1/p62 by an enteroviral protease results in disrupted selective autophagy and impaired NFKB signaling. Autophagy 9:1591–1603. doi:10.4161/auto.26059</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.26059</ArticleId><ArticleId IdType="pubmed">23989536</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhou X, Chen S, Sun X, Zhou C. 2023. Immune mechanisms of group B coxsackievirus induced viral myocarditis. Virulence 14:2180951. doi:10.1080/21505594.2023.2180951</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2023.2180951</ArticleId><ArticleId IdType="pmc">PMC9980623</ArticleId><ArticleId IdType="pubmed">36827455</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Yang Z, Nie W, Jiang J, Li S, Li Z, Tian L, Ma X. 2019. Exosomes derived from cardiac progenitor cells attenuate CVB3-induced apoptosis via abrogating the proliferation of CVB3 and modulating the mTOR signaling pathways. Cell Death Dis 10:691. doi:10.1038/s41419-019-1910-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1910-9</ArticleId><ArticleId IdType="pmc">PMC6751166</ArticleId><ArticleId IdType="pubmed">31534118</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhao S, Chen Y, Wang T, Dong C, Wo X, Zhang J, Dong Y, Xu W, Feng X, Qu C, Wang Y, Zhong Z, Zhao W. 2019. The capsid protein VP1 of coxsackievirus B induces cell cycle arrest by up-regulating heat shock protein 70. Front Microbiol 10:1633. doi:10.3389/fmicb.2019.01633</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2019.01633</ArticleId><ArticleId IdType="pmc">PMC6653663</ArticleId><ArticleId IdType="pubmed">31379784</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zeng L, Liu Q, Jin G, Zhang J, Li Z, Xu Y, Tian H, Deng S, Shi Q, Huang X. 2021. CVB3 VP1 interacts with MAT1 to inhibit cell proliferation by interfering with Cdk-activating kinase complex activity in CVB3-induced acute pancreatitis. PLoS Pathog 17:e1008992. doi:10.1371/journal.ppat.1008992</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008992</ArticleId><ArticleId IdType="pmc">PMC7895353</ArticleId><ArticleId IdType="pubmed">33556114</ArticleId></ArticleIdList></Reference><Reference><Citation>Henke A, Nestler M, Strunze S, Saluz HP, Hortschansky P, Menzel B, Martin U, Zell R, Stelzner A, Munder T. 2001. The apoptotic capability of coxsackievirus B3 is influenced by the efficient interaction between the capsid protein VP2 and the proapoptotic host protein Siva. Virology (Auckl) 289:15–22. doi:10.1006/viro.2001.1082</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.1082</ArticleId><ArticleId IdType="pubmed">11601913</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowlton KU, Jeon ES, Berkley N, Wessely R, Huber S. 1996. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the woodruff variant of coxsackievirus B3. J Virol 70:7811–7818. doi:10.1128/jvi.70.11.7811-7818.1996</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.70.11.7811-7818.1996</ArticleId><ArticleId IdType="pmc">PMC190851</ArticleId><ArticleId IdType="pubmed">8892902</ArticleId></ArticleIdList></Reference><Reference><Citation>Kicmal TM, Tate PM, Dial CN, Esin JJ, Mounce BC. 2019. Polyamine depletion abrogates enterovirus cellular attachment. J Virol 93:20. doi:10.1128/JVI.01054-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01054-19</ArticleId><ArticleId IdType="pmc">PMC6798109</ArticleId><ArticleId IdType="pubmed">31341056</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Pfeiffer JK. 2016. Emergence of a large-plaque variant in mice infected with coxsackievirus B3. MBio 7:e00119. doi:10.1128/mBio.00119-16</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00119-16</ArticleId><ArticleId IdType="pmc">PMC4817249</ArticleId><ArticleId IdType="pubmed">27025249</ArticleId></ArticleIdList></Reference><Reference><Citation>Chehadeh W, Lobert P-E, Sauter P, Goffard A, Lucas B, Weill J, Vantyghem M-C, Alm G, Pigny P, Hober D. 2005. Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of alpha interferon. J Virol 79:13882–13891. doi:10.1128/JVI.79.22.13882-13891.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.22.13882-13891.2005</ArticleId><ArticleId IdType="pmc">PMC1280186</ArticleId><ArticleId IdType="pubmed">16254324</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao J, Sun T, Yue Y, Xiong S. 2019. Macrophage NLRP3 inflammasome activated by CVB3 capsid proteins contributes to the development of viral myocarditis. Mol Immunol 114:41–48. doi:10.1016/j.molimm.2019.07.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2019.07.012</ArticleId><ArticleId IdType="pubmed">31336248</ArticleId></ArticleIdList></Reference><Reference><Citation>Stadnick E, Dan M, Sadeghi A, Chantler JK. 2004. Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3. J Virol 78:13987–14002. doi:10.1128/JVI.78.24.13987-14002.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.24.13987-14002.2004</ArticleId><ArticleId IdType="pmc">PMC533932</ArticleId><ArticleId IdType="pubmed">15564506</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Ding W, Zhang J, Gao Q, Yang H, Cao W, Wang Z, Fang L, Du R. 2019. Significant down-regulation of urea cycle generates clinically relevant proteomic signature in hepatocellular carcinoma patients with macrovascular invasion. J Proteome Res 18:2032–2044. doi:10.1021/acs.jproteome.8b00921</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.8b00921</ArticleId><ArticleId IdType="pubmed">30901224</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SS, Xu S, Cui J, Poddar S, Le TM, Hayrapetyan H, Li L, Wu N, Moore AM, Zhou L, Yu AC, Dann AM, Elliott IA, Abt ER, Kim W, Dawson DW, Radu CG, Donahue TR. 2020. Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression. Theranostics 10:829–840. doi:10.7150/thno.40195</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.40195</ArticleId><ArticleId IdType="pmc">PMC6929997</ArticleId><ArticleId IdType="pubmed">31903153</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman LA, Ku W-M, Heslin MJ, Contreras CM, Skibola CF, Nomura DK. 2017. Argininosuccinate synthase 1 is a metabolic regulator of colorectal cancer pathogenicity. ACS Chem Biol 12:905–911. doi:10.1021/acschembio.6b01158</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschembio.6b01158</ArticleId><ArticleId IdType="pubmed">28229591</ArticleId></ArticleIdList></Reference><Reference><Citation>Shan Y-S, Hsu H-P, Lai M-D, Yen M-C, Chen W-C, Fang J-H, Weng T-Y, Chen Y-L. 2015. Argininosuccinate synthetase 1 suppression and arginine restriction inhibit cell migration in gastric cancer cell lines. Sci Rep 5:9783. doi:10.1038/srep09783</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep09783</ArticleId><ArticleId IdType="pmc">PMC4415574</ArticleId><ArticleId IdType="pubmed">25928182</ArticleId></ArticleIdList></Reference><Reference><Citation>Szlosarek PW, Grimshaw MJ, Wilbanks GD, Hagemann T, Wilson JL, Burke F, Stamp G, Balkwill FR. 2007. Aberrant regulation of argininosuccinate synthetase by TNF-alpha in human epithelial ovarian cancer. Int J Cancer 121:6–11. doi:10.1002/ijc.22666</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.22666</ArticleId><ArticleId IdType="pubmed">17354225</ArticleId></ArticleIdList></Reference><Reference><Citation>Orecchioni M, Ghosheh Y, Pramod AB, Ley K. 2019. Macrophage polarization: different gene signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. alternatively activated macrophages. Front Immunol 10:1084. doi:10.3389/fimmu.2019.01084</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01084</ArticleId><ArticleId IdType="pmc">PMC6543837</ArticleId><ArticleId IdType="pubmed">31178859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciesielski O, Biesiekierska M, Panthu B, Soszyński M, Pirola L, Balcerczyk A. 2022. Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives. Cell Mol Life Sci 79:94. doi:10.1007/s00018-022-04126-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-022-04126-3</ArticleId><ArticleId IdType="pmc">PMC8788905</ArticleId><ArticleId IdType="pubmed">35079870</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero MJ, Platt DH, Caldwell RB, Caldwell RW. 2006. Therapeutic use of citrulline in cardiovascular disease. Cardiovasc Drug Rev 24:275–290. doi:10.1111/j.1527-3466.2006.00275.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1527-3466.2006.00275.x</ArticleId><ArticleId IdType="pubmed">17214603</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamud Y, Shi J, Qu J, Poon T, Xue YC, Deng H, Zhang J, Luo H. 2018. Enteroviral infection inhibits autophagic flux via disruption of the SNARE complex to enhance viral replication. Cell Rep 22:3292–3303. doi:10.1016/j.celrep.2018.02.090</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.02.090</ArticleId><ArticleId IdType="pubmed">29562184</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Zhao E, Ilyas G, Lalazar G, Lin Y, Haseeb M, Tanaka KE, Czaja MJ. 2015. Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization. Autophagy 11:271–284. doi:10.1080/15548627.2015.1009787</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2015.1009787</ArticleId><ArticleId IdType="pmc">PMC4502775</ArticleId><ArticleId IdType="pubmed">25650776</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan P, Song X, Tran J, Zhou R, Cao X, Zhao G, Yuan H. 2022. Dapagliflozin alleviates coxsackievirus B3-induced acute viral myocarditis by regulating the macrophage polarization through Stat3-related pathways. Inflammation 45:2078–2090. doi:10.1007/s10753-022-01677-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-022-01677-2</ArticleId><ArticleId IdType="pmc">PMC9499897</ArticleId><ArticleId IdType="pubmed">35676606</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>